UBS lowered the firm’s price target on Marsh McLennan (MMC) to $257 from $258 and keeps a Buy rating on the shares. Property and casualty insurance stocks underperformed in Q3, but lighter catastrophe losses support higher earnings estimates, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMC:
- Marsh McLennan price target lowered to $221 from $233 at Barclays
- Marsh McLennan price target lowered to $215 from $220 at Morgan Stanley
- Marsh McLennan price target lowered to $209 from $210 at Keefe Bruyette
- Wolfe Research launches coverage with positive view on Life Insurance names
- Marsh McLennan initiated with a Peer Perform at Wolfe Research